Results From the REsCue Trial: A Randomized Controlled Trial with Extended-Release Calcifediol in Symptomatic Outpatients with COVID-19

Charles W. Bishop, Akhtar Ashfaq, Joel Z. Melnick, Enrique Vazquez-Escarpanter, Jonathan A. Fialkow, Stephen A. Strugnell, John Choe, Kamyar Kalantar-Zadeh, Noah C. Federman, David Ng, John S. Adams
doi: https://doi.org/10.1101/2022.01.31.22270036

Data Availability

All top-line data produced in the present study are contained in the manuscript. Additional analyses are ongoing as further laboratory data become available.

Back to top
Posted February 05, 2022.
Download PDF
Data/Code
Email
Results From the REsCue Trial: A Randomized Controlled Trial with Extended-Release Calcifediol in Symptomatic Outpatients with COVID-19
Charles W. Bishop, Akhtar Ashfaq, Joel Z. Melnick, Enrique Vazquez-Escarpanter, Jonathan A. Fialkow, Stephen A. Strugnell, John Choe, Kamyar Kalantar-Zadeh, Noah C. Federman, David Ng, John S. Adams
medRxiv 2022.01.31.22270036; doi: https://doi.org/10.1101/2022.01.31.22270036
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area